Mrv1533007101513152D 19 20 0 0 0 0 999 V2000 2.8578 2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -2.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5723 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5723 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5723 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -2.4750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 -1.6500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.5723 2.0625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 1.2375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5 4 2 0 0 0 0 8 6 1 0 0 0 0 9 7 1 0 0 0 0 11 4 1 0 0 0 0 11 10 1 0 0 0 0 12 5 1 0 0 0 0 13 11 2 0 0 0 0 14 12 2 0 0 0 0 14 13 1 0 0 0 0 15 6 1 0 0 0 0 15 7 1 0 0 0 0 17 1 1 0 0 0 0 17 12 1 0 0 0 0 18 2 1 0 0 0 0 18 13 1 0 0 0 0 19 3 1 0 0 0 0 19 14 1 0 0 0 0 16 8 1 0 0 0 0 16 9 1 0 0 0 0 16 10 1 0 0 0 0 M END > DB09069 > drugbank > COC1=C(OC)C(OC)=C(CN2CCNCC2)C=C1 > InChI=1S/C14H22N2O3/c1-17-12-5-4-11(13(18-2)14(12)19-3)10-16-8-6-15-7-9-16/h4-5,15H,6-10H2,1-3H3 > UHWVSEOVJBQKBE-UHFFFAOYSA-N > C14H22N2O3 > 266.341 > 266.163042576 > 5 > 41 > 29.154820146078933 > 1 > 1 > 0 > 1 > 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine > 0.85 > 0.9057004276666669 > -2.55 > 0 > 2 > 1 > 9.2147612185944 > 42.96000000000001 > 74.74570000000001 > 5 > 1 > 7.54e-01 g/l > trimetazidine > 0 > DB09069 > approved; investigational > Trimetazidine > 1-[2,3,4-trimethoxybenzyl] piperazine dihydrochloride; Trimetazidina; Trimetazidine > Vastarel MR > Trimetazidine dihydrochloride $$$$